Horizons in Sjögren's syndrome genetics

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 3, 2007, Pages 201-209

  Williams, Pamela H ^a   Cobb, Beth L ^a   Namjou, Bahram ^a   Scofield, R Hal ^a,b,c   Sawalha, Amr H ^a,b,c   Harley, John B ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Genetics; Histocompatibility; HLA; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; GASTROINTESTINAL HORMONE; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; LEUKOCYTE ANTIGEN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLOTYPE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DRY EYE; GENE EXPRESSION; GENE STRUCTURE; GENE TRANSFER; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; HEREDITY; HLA SYSTEM; LYMPHADENITIS; MICROSATELLITE MARKER; NONHUMAN; PROMOTER REGION; REVIEW; SIALOADENITIS; SJOEGREN SYNDROME; XEROSTOMIA;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; MICE; SJOGREN'S SYNDROME;

EID: 36949027133     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8002-9     Document Type: Review

References (76)

1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjogren's S (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558
2. Lisch K (1937) Uber hereditarisches vorkommen des mit keratoconjuctivitis sicca verbunden Sjogrenschen symptomenkomplexes. Arch Augenheilkd 110:357
3. Reveille JD, Wilson RW, Provost TT, Bias WB, Arnett FC (1984) Primary Sjogren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 101:748-756
4. Whittingham S, Propert DN, Mackay IR (1984) A strong Xassociation between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1). Immunogenetics 19:295-299
5. Pertovaara M, Hurme M, Antonen J, Pasternack A, Pandey JP (2004) Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjogren's syndrome. J Rheumatol 31:2175-2180
6. Kim T-H, Uhm W-S, Inman RD (2005) Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 17:400-405
7. Pauling L, Itano H, Singer S, Wells I (1949) Sickle cell anemia, a molecular disease. Science 110:543-548
8. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies [see comment]. Nat Genet 29:306-309
9. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VEH, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561-571
10. Gottenberg J-E, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X (2003) In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 48:2240-2245
11. Fye KH, Terasaki PI, Moutsopoulos H, Daniels TE, Michalski JP, Talal N (1976) Association of Sjogren's syndrome with HLA-B8. Arthritis Rheum 19:883-886
12. Gershwin ME, Terasaki I, Graw R, Chused TM (1975) Increased frequency of HL-A8 in Sjogren's syndrome. Tissue Antigens 6:342-346
13. Chused TM, Kassan SS, Opelz G, Moutsopoulos HM, Terasaki PI (1977) Sjogren's syndrome association with HLA-Dw3. N Engl J Med 296:895-897
14. Guggenbuhl P, Veillard E, Quelvenec E, Jego P, Semana G, Jean S, Meadeb J, Chales G, Perdriger A (2000) Analysis of TNFalpha microsatellites in 35 patients with primary Sjogren's syndrome. Joint, Bone, Spine: Revue du Rhumatisme 67:290-295
15. Kumagai S, Kanagawa S, Morinobu A, Takada M, Nakamura K, Sugai S, Maruya E, Saji H (1997) Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjogren's syndrome. Arthritis Rheum 40:1685-1692
16. Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G (1998) DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin Exp Rheumatol 16:725-728
17. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martin J (2005) PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 6:628-631
18. Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR, Baechler EC, Rohlf KE, Shark KB, Espe KJ, Green LE, Nair RP, Stuart PE, Elder JT, King RA, Moser KL, Gaffney PM, Bugawan TL, Erlich HA, Rich SS, Gregersen PK, Behrens TW (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71:543-553
19. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986) Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 232:1145-1147
20. Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219-224
21. Ittah M, Gottenberg JE, Proust A, Hachulla E, Puechal X, Loiseau P, Mariette X, Miceli-Richard C (2005) No evidence for association between 1858 C≠T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome. Genes Immun 6:457-458
22. Petrek M, Cermakova Z, Hutyrova B, Micekova D, Drabek J, Rovensky J, Bosak V (2002) CC ckemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 20:701-703
23. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40:656-661
24. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B (1998) IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87:309-313
25. Ramos-Casals M, Font J, Brito-Zeron P, Trejo O, Garcia-Carrasco M, Lozano F (2004) Interleukin-4 receptor alpha polymorphisms in primary Sjogren's syndrome. Clin Exp Rheumatol 22:374
26. Bolstad AI, Wargelius A, Nakken B, al E (2000) Fas and Fas Ligand gene polymorphisms in priary Sjogren's syndrome. J Rheumatol 27:2397-2405
27. Mullighan CG, Heatley S, Bardy PG, Lester S, Rischmueller M, Gordon TP (2000) Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 43:2851-2852
28. Pertovaara M, Lehtimaki T, Rontu R, Antonen J, Pasternack A, Hurme M (2004) Presence of apolipoprotein E epsilon 4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology 43:1484-1487
29. Wang ZY, Morinobu A, Kanagawa S, Kumagai S (2001) Polymorphisms of the mannose binding lectin gene in patients with Sjogren's syndrome. Ann Rheum Dis 60:483-486
30. Harangi M, Kaminski WE, Fleck M, Orso E, Zeher M, Kiss E, Szekanecz Z, Zilahi E, Marienhagen J, Aslanidis C, Paragh G, Bolstad AI, Jonsson R, Schmitz G (2005) Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur J Immunol 35:305-317
31. Youn J, Hwang SH, Cho CS, Min JK, Kim WU, Park SH, Kim HY (2000) Association of the interleukin-4 receptor alpha variant Q576R with Th1/Th2 imbalance in connective tissue disease. Immunogenetics 51:743-746
32. Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, Ida H, Kawakami A, Migita K, Eguchi K (2003) Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome. Ann Rheum Dis 62:1117-1118
33. Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, Vives J, Yague J (2002) The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology 41:1025-1030
34. Rischmueller M, Limaye V, Lester S, al E (2000) Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J Rheumatol 27:2945-2946
35. Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T (2001) Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun 2:99-104
36. Aittoniemi J, Pertovaara M, Hulkkonen J, Pasternack A, Hurme M, Laippala P, Antonen J (2002) The significance of mannan-binding lectin gene alleles in patients with primary Sjogren's syndrome. Scand J Rheumatol 31:362-365
37. Nakken B, Jonsson R, Bolstad AI (2001) Polymorphisms of the Ro52 Gene Associated with Anti-Ro 52-kd Autoantibodies in Patients With Primary Sjogren's Syndrome Arthritis Rheum 44:636-638
38. Imanishi T, Morinobu A, Hayashi N, Kanagawa S, Koshiba M, Kondo S, Kumagai S (2005) A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjogren's syndrome. Clin Exp Rheumatol 23:521-524
39. Lawson CA, Donaldson IJ, Bowman SJ, Shefta J, Morgan AW, Gough A, Isaacs JD, Griffiths B, Emery P, Pease CT, Boylston AW (2005) Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjogren's syndrome. Ann Rheum Dis 64:468-470
40. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scand J Immunol 55:336-342
41. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276:604-607
42. Kuwana M, Okano T, Ogawa Y, Kaburaki J, Kawakami Y (2001) Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjogren's syndrome. J Immunol 167:5449-5456
43. Billaut-Mulot O, Cocude C, Kolesnitchenko V, Truong MJ, Chan EK, Hachula E, de la Tribonniere X, Capron A, Bahr GM (2001) SS-56, a novel cellular target of autoantibody responses in Sjogren's syndrome and systemic lupus erythematosus. J Clin Invest 108:861-869
44. Tanaka AR, Ikeda Y, Abe-Dohmae S, Arakawa R, Sadanami K, Kidera A, Nakagawa S, Nagase T, Aoki R, Kioka N, Amachi T, Yokoyama S, Ueda K (2001) Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's syndrome. Biochem Biophys Res Commun 283:1019-1025
45. Tsukada Y, Ichikawa H, Chai Z, Lai FP, Dunster K, Sentry JW, Toh BH (2000) Novel variant of p230 trans-Golgi network protein identified by serum from Sjogren's syndrome patient. Eur J Cell Biol 79:790-794
46. Griffith KJ, Chan EK, Lung CC, Hamel JC, Guo X, Miyachi K, Fritzler MJ (1997) Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjogren's syndrome. Arthritis Rheum 40:1693-1702
47. Matsumoto I, Maeda T, Takemoto Y, Hashimoto Y, Kimura F, Iwamoto I, Saito Y, Nishioka K, Sumida T (1999) Alpha-amylase functions as a salivary gland-specific self T cell epitope in patients with Sjogren's syndrome. Int J Mol Med 3:485-490
48. Beroukas D, Goodfellow R, Hiscock J, Jonsson R, Gordon TP, Waterman SA (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren's syndrome. Lab Invest 82:203-210
49. Tapinos NI, Polihronis M, Thyphronitis G, Moutsopoulos HM (2002) Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjogren's syndrome. Arthritis Rheum 46:215-222
50. Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C (2001) Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients. Lab Invest 81:143-148
51. Cavill D, Waterman SA, Gordon TP (2002) Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjogren's syndrome. J Rheumatol 29:1342-1344
52. Tominaga M, Migita K, Sano H, Fukui W, Kohno M, Tsubouchi Y, Honda S, Fukuda T, Nakamura H, Yamasaki S, Kawabe Y, Kawakami A, Eguchi K (2000) Expression of cyclooxygenase-1 (COX-1) in labial salivary glands of Sjogren's syndrome. Clin Exp Immunol 122:459-463
53. Boulard O, Fluteau G, Eloy L, Damotte D, Bedossa P, Garchon H-J (2002) Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 168:4192-4201
54. Brayer J, Lowry J, Cha S, Robinson CP, Yamachika S, Peck AB, Humphreys-Beher MG (2000) Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy. J Rheumatol 27:1896-1904
55. Johansson ACM, Nakken B, Sundler M, Lindqvist A-KB, Johannesson M, Alarcon-Riquelme M, Bolstad AI, Humphreys-Beher MG, Jonsson R, Skarstein K, Holmdahl R (2002) The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol 32:243-250
56. Esch TR, Poveromo JD, Aikins MC, Levanos VA (2002) A novel lacrimal gland autoantigen in the NOD mouse model of Sjogren's syndrome. Scand J Immunol 55:304-310
57. Yamachika S, Nanni JM, Nguyen KH, Garces L, Lowry JM, Robinson CP, Brayer J, Oxford GE, da Silveira A, Kerr M, Peck AB, Humphreys-Beher MG (1998) Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjogren's syndrome. J Rheumatol 25:2371-2380
58. Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB, Humphreys-Beher MG (1997) Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome. Proc Natl Acad Sci U S A 94:5767-5771
59. Humphreys-Beher MG (1996) Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 10:73-75
60. Yanagi K, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y (1998) Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjogren's syndrome. Eur J Immunol 28:3336-33450
61. Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc Natl Acad Sci U S A 95:7538-7543
62. Robinson CP, Yamachika S, Bounous DI, Brayer J, Jonsson R, Holmdahl R, Peck AB, Humphreys-Beher MG (1998) A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum 41:150-156
63. Singh AK (1995) Lupus in the Fas lane? J R Coll Physicians Lond 29:475-478
64. Haneji N, Hamano H, Yanagi K, Hayashi Y (1994) A new animal model for primary Sjogren's syndrome in NFS/sld mutant mice. J Immunol 153:2769-2777
65. Fujita H, Fujihara T, Takeuchi T, Saito I, Tsubota K (1998) Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice. Adv Exp Med Biol 438:941-948
66. Wahren M, Skarstein K, Blange I, Pettersson I, Jonsson R (1994) MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. Immunology 83:9-15
67. Kimura T, Suzuki K, Inada S, Hayashi A, Saito H, Miyai T, Ohsugi Y, Matsuzaki Y, Tanaka N, Osuga T et al (1994) Induction of autoimmune disease by graft-versus-host reaction across MHC class II difference: modification of the lesions in IL-6 transgenic mice. Clin Exp Immunol 95:525-529
68. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K, Matsuura Y, Miyamura T (1997) Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A 94:233-236
69. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J (1999) Sjogren's syndrome and hepatitis C virus. Clin Rheumatol 18:93-100
70. Tsubata R, Tsubata T, Hiai H, Shinkura R, Matsumura R, Sumida T, Miyawaki S, Ishida H, Kumagai S, Nakao K, Honjo T (1996) Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome. Eur J Immunol 26:2742-2748
71. Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjogren's syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 41:2175-2184
72. Lodde BM, Mineshiba F, Wang J, Cotrim AP, Afione S, Tak PP, Baum BJ (2006) Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis 65:195-200
73. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 162:1707-1716
74. Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J (2002) Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 80:16-24
75. Pozo D, Delgado M, Martinez M, Guerrero JM, Leceta J, Gomariz RP, Calvo JR (2000) Immunobiology of vasoactive intestinal peptide (VIP)[erratum appears in Immunol Today 2000 Apr;21(4):191]. Immunol Today 21:7-11
76. Grimm MC, Newman R, Hassim Z, Cuan N, Connor SJ, Le Y, Wang JM, Oppenheim JJ, Lloyd AR (2003) Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol 171:4990-4994